DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Peptide Therapeutics Market & Clinical Pipeline Insight 2016" drug pipelines to their offering.
Significant investments have been made by pharmaceutical companies in research and development (R&D) segment in order to come forth with innovative products. They also serve as building blocks for other therapeutics due to which it has become essential to study their nature in depth. In this way, it could be expected that peptide therapeutics for different ailments would be commercialized in global market in coming years.
The pipeline of peptide therapeutics is quite strong due to which new products are expected to enter in global market in coming years. Several peptide therapeutics have already entered in various phases of clinical trials. Development of positive results will accelerate their market introduction in coming years. They are peptide in nature due to which chances of degradation is high, poor chemical stability and absorbance are some common caveats with their development.
Rapid discovery of peptide therapeutics is expected to increase the number of products in global market. Investigators are developing methods to identify new lead molecules that will serve as a basis for the development of new molecule. They are also being administrated in combination with other drugs to achieve higher therapeutic benefits.
Key Topics Covered:
1. Introduction to Peptides
2. Mechanism of Action: Peptide Therapeutics, Peptide Vaccine & Peptide Hormone
3. Global Peptide Therapeutics Market Overview
4. Global Peptide Therapeutics Market Dynamics
5. Global Peptide Therapeutics Market Future Prospects
6. Cyclic Peptides Clinical Insight by Company, Indication & Phase
7. Dipeptides Clinical Insight by Company, Indication & Phase
8. Depsipeptides Clinical Insight by Company, Indication & Phase
9. Glycopeptide Clinical Insight by Company, Indication & Phase
10. Insulin Clinical Insight by Company, Indication & Phase
11. Lipopeptides Clinical Insight by Company, Indication & Phase
12. Natriuretic Peptide Clinical Insight by Company, Indication & Phase
13. Neuropeptide Clinical Insight by Company, Indication & Phase
14. Oligopeptides Clinical Insight by Company, Indication & Phase
15. Opioid-Peptide Clinical Insight by Company, Indication & Phase
16. Peptides Clinical Insight by Company, Indication & Phase
17. Multiple Peptides Clinical Insight by Company, Indication & Phase
18. Marketed Peptides Clinical Insight by Company, Indication & Phase
19. Competitive Landscape
Companies Profiled:
- Amgen
- Amylin Pharmaceuticals
- Apitope Technology
- BiondVax Pharmaceuticals Ltd
- BioPartners
- Boehringer Ingelheim
- Circassia
- Corden Pharma (Peptisyntha)
- Eli Lily
- Galena Biopharmaceuticals
- GlaxoSmithKline
- (10+ Others)
For more information visit http://www.researchandmarkets.com/research/tqf3kq/global_peptide
